Tesamorelin is the active drug substance in an FDA-approved finished product (NDA 022505, Theratechnologies), originally approved November 10, 2010
However, it's important to remember that peptides are not a "quick fix" for muscle growth
Patel developed a patented, first-of-its-kind technology that optimizes antioxidant absorption and efficacy for better health and better results
It does not significantly raise IGF-1 or systemic growth hormone levels
Complete blood count and metabolic panels as part of comprehensive health monitoring
Contraindications, precautions : The drug should never be taken by pregnant women, patients with early hereditary optic nerve atrophy, hypersensitivity to cyanocobalamin, hypersensitivity to cobalt